Senescence: a new weapon for cancer therapy.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMID 22245068)

Published in Trends Cell Biol on January 13, 2012

Authors

Juan Carlos Acosta1, Jesús Gil

Author Affiliations

1: Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London W12 0NN, UK.

Articles citing this

Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol (2013) 1.34

Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion. Aging (Albany NY) (2012) 1.00

Deoxyribonucleotide metabolism, mutagenesis and cancer. Nat Rev Cancer (2015) 0.96

Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer. Mol Cancer Res (2013) 0.93

Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor. Oncogene (2015) 0.91

A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation. Mol Cancer (2013) 0.90

Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res (2014) 0.89

Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies. Oxid Med Cell Longev (2015) 0.88

CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner. Sci Rep (2013) 0.88

α-Fucosidase as a novel convenient biomarker for cellular senescence. Cell Cycle (2013) 0.86

Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6. Cancer Res (2016) 0.85

Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition. Mol Biol Cell (2015) 0.85

HiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression. Cancers (Basel) (2014) 0.85

DDR-mediated crosstalk between DNA-damaged cells and their microenvironment. Front Genet (2015) 0.82

Repopulation of ovarian cancer cells after chemotherapy. Cancer Growth Metastasis (2013) 0.82

Wnt5a Signaling in Cancer. Cancers (Basel) (2016) 0.81

New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers. Front Oncol (2013) 0.81

Long Term Exposure to Polyphenols of Artichoke (Cynara scolymus L.) Exerts Induction of Senescence Driven Growth Arrest in the MDA-MB231 Human Breast Cancer Cell Line. Oxid Med Cell Longev (2015) 0.81

Exploiting tumor cell senescence in anticancer therapy. BMB Rep (2014) 0.80

PKCη promotes senescence induced by oxidative stress and chemotherapy. Cell Death Dis (2014) 0.79

Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis. Cell Death Differ (2013) 0.79

Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases. Radiat Res (2016) 0.78

Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways. Neuro Oncol (2014) 0.78

The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype. Cancer Biol Ther (2013) 0.78

Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization. Hepatology (2016) 0.77

A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells. Cell Cycle (2016) 0.77

Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer. Oncotarget (2016) 0.77

SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer. Genes Dev (2016) 0.75

Guiqi polysaccharide protects the normal human fetal lung fibroblast WI-38 cells from H2O2-induced premature senescence. Int J Clin Exp Pathol (2015) 0.75

Too much or too little: harnessing senescence to control oncogene-driven cancer. Cell Cycle (2012) 0.75

Deciphering the molecular mechanisms underlying the binding of the TWIST1/E12 complex to regulatory E-box sequences. Nucleic Acids Res (2016) 0.75

Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers. Oncotarget (2016) 0.75

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells. Proc Natl Acad Sci U S A (2017) 0.75

Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells. Viruses (2017) 0.75

miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14. Cell Death Dis (2017) 0.75

Teng-Long-Bu-Zhong-Tang induces p21-dependent cell senescence in colorectal carcinoma LS174T cells via histone acetylation. J Exp Pharmacol (2017) 0.75

The Immortal Senescence. Methods Mol Biol (2017) 0.75

Articles by these authors

Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15

Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65

Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94

Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev (2009) 4.69

A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98

Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev (2009) 2.98

Myc confers androgen-independent prostate cancer cell growth. J Clin Invest (2003) 1.65

Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics (2010) 1.63

Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep (2010) 1.38

Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev (2012) 1.34

Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression. Cell Stem Cell (2012) 1.33

Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell (2011) 1.33

A role for CXCR2 in senescence, but what about in cancer? Cancer Res (2009) 1.19

Control of senescence by CXCR2 and its ligands. Cell Cycle (2008) 1.17

Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene (2002) 1.15

DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts. Aging Cell (2013) 0.90

Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation. EMBO J (2013) 0.89

A genetic screen identifies topoisomerase 1 as a regulator of senescence. Cancer Res (2009) 0.86

Unbiased characterization of the senescence-associated secretome using SILAC-based quantitative proteomics. Methods Mol Biol (2013) 0.83

Design of a soil cutting resistance sensor for application in site-specific tillage. Sensors (Basel) (2013) 0.79

Design of a new sensor for determination of the effects of tractor field usage in southern Spain: soil sinkage and alterations in the cone index and dry bulk density. Sensors (Basel) (2012) 0.78

New apocarotenoids and β-carotene cleavage in Blakeslea trispora. Org Biomol Chem (2011) 0.77

Structure-activity relationship in the interaction of substituted perinaphthenones with Mycosphaerella fijiensis. J Agric Food Chem (2009) 0.77

The cerebral cavernous malformation 3 gene is necessary for senescence induction. Aging Cell (2015) 0.77

Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes. Cell Cycle (2013) 0.77

Primary cilia and senescence: a sensitive issue. Cell Cycle (2014) 0.75

Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol (2015) 0.75

[Evaluation E-test method to determine the antimicrobial activity of ceftaroline against methicillin-resistant strains of Staphylococcus aureus]. Rev Esp Quimioter (2014) 0.75

Postoperative costs associated with outcomes after cardiac surgery with extracorporeal circulation: role of antithrombin levels. J Cardiothorac Vasc Anesth (2012) 0.75